The Zetia controversy and New Year's resolutions will spark new emphasis on treating lipids

January 2010

The Zetia controversy and New Year's resolutions will spark new emphasis on treating lipids...especially when combo therapy is needed.

We know statins are first-line for lowering LDL and cardiac risk.

But they don't always get patients to their lipid goals. And experts differ about what to do when a statin isn't enough.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cardiology The Zetia controversy and New Year's resolutions will spark new emphasis on treating lipids
Gastroenterology Ondansetron is being used more for acute nausea and vomiting
Migraine Sumavel DosePro, a new NEEDLE-FREE sumatriptan injection for migraines
Women s Health oral bisphosphonates (Fosamax, etc) might decrease the risk of breast cancer
Women s Health more emphasis on avoiding valproate during pregnancy
Cardiology whether warfarin is beneficial for MODERATE-risk patients with atrial fibrillation
Respiratory Allergy whether saline nasal irrigation or "neti pots" increase sinus infections
Psychiatry increasing use of atypical antipsychotics in children
Supplements high-dose folic acid supplements might INCREASE cancer risk
Supplements ensuring kids get enough vitamin D
Obesity Weight Loss people will be trying various products to try to lose weight
Interactions a specific list of drugs to avoid with Plavix
Cardiology using IV iron to improve heart failure symptoms